RHOA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.765000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.109250E-01
Normal-vs-Stage2
5.655800E-01
Normal-vs-Stage3
3.053600E-01
Normal-vs-Stage4
8.714000E-01
Stage1-vs-Stage2
1.220180E-01
Stage1-vs-Stage3
8.620800E-01
Stage1-vs-Stage4
7.801700E-02
Stage2-vs-Stage3
3.039800E-01
Stage2-vs-Stage4
4.222200E-01
Stage3-vs-Stage4
2.365800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.632000E-01
Normal-vs-AfricanAmerican
5.705800E-01
Normal-vs-Asian
3.342800E-01
Caucasian-vs-AfricanAmerican
9.068200E-01
Caucasian-vs-Asian
6.885200E-01
AfricanAmerican-vs-Asian
8.912600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.833400E-01
Normal-vs-Female
4.640400E-01
Male-vs-Female
8.401600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.248400E-02
Normal-vs-Age(41-60Yrs)
7.010000E-01
Normal-vs-Age(61-80Yrs)
4.303400E-01
Normal-vs-Age(81-100Yrs)
2.553600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.356100E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.764600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.448000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.052000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.606430E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.058600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.697000E-01
Normal-vs-Daily Drinker
3.339000E-01
Normal-vs-Weekly Drinker
5.417000E-01
Normal-vs-Occasional Drinker
6.626000E-01
Normal-vs-Social Drinker
2.998600E-01
Non Drinker-vs-Daily Drinker
9.910000E-01
Non Drinker-vs-Weekly Drinker
4.167400E-01
Non Drinker-vs-Occasional Drinker
2.727400E-01
Non Drinker-vs-Social Drinker
8.765800E-01
Daily Drinker-vs-Weekly Drinker
4.009600E-01
Daily Drinker-vs-Occasional Drinker
2.675200E-01
Daily Drinker-vs-Social Drinker
8.841200E-01
Weekly Drinker-vs-Occasional Drinker
8.225800E-01
Weekly Drinker-vs-Social Drinker
3.530800E-01
Occasional Drinker-vs-Social Drinker
2.448000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.397400E-01
Normal-vs-Grade 2
6.434200E-01
Normal-vs-Grade 3
6.706400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.397700E-04
Grade 1-vs-Grade 3
1.837600E-02
Grade 1-vs-Grade 4
8.397400E-01
Grade 2-vs-Grade 3
5.172400E-01
Grade 2-vs-Grade 4
6.434200E-01
Grade 3-vs-Grade 4
6.706400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.576000E-01
Normal-vs-NonDiabetic
4.184200E-01
Diabetic-vs-NonDiabetic
8.657000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.437600E-01
Normal-vs-NoPancreatitis
4.621200E-01
Pancreatitis-vs-NoPancreatitis
9.255600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.449800E-01
Normal-vs-N1
5.361800E-01
N0-vs-N1
5.977400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.170800E-01
Normal-vs-TP53-NonMutant
2.235100E-03
TP53-Mutant-vs-TP53-NonMutant
4.46670000000537E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
